Potential breaches have been identified in sterile packaging of the HLS and PLS sets used for extracorporeal respiratory and/or cardiovascular support.
The AI vocal biomarker firm will use funding to accelerate its commercial growth, expand its platform into new health conditions, and enter new geographies.